drugset / Trial / NCT05264558
Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30%
Phase 4
Completed
606 enrolled
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Cairns Hinterland Health Hospital and Health Services · collabThe University of Queensland · collab
Non-randomizedCrossoverOpen-labelTreatment
Summary
The study aims to assess the impact of models of HCV care on HCV testing, treatment uptake and cure within Cairns. Point of care testing for HCV , with test and treat strategies will be offered within a primary care service.
Timeline
- Start
- 2022-07-25
- Primary completion
- 2023-08-31
- Completion
- 2023-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sofosbuvir | Small molecule | 400 mg | — |
| Subject | velpatasvir | Other / unclassified | 100 mg | — |